Authors
Ni Wayan Armerinayanti, Desak Putu Oki Lestari, I Gede Wikania Wira Wiguna
Published in
Asian Pacific journal of cancer prevention : APJCP. Volume 27. Issue 8. Pages 2931-2940. Aug 01, 2026. Epub Aug 01, 2026.
Abstract
High-grade tumor budding (HGTB) is still a controversial parameter in determining the aggressiveness of cervical carcinoma, yet the molecular mechanism of TB is still not comprehensively understood. This study aimed to evaluate whether miR-21, mutant p53, and MMP-9 expression are associated with HGTB in cervical carcinoma.
This nested case-control study was conducted at the Anatomical Pathology Laboratory of Balimed Denpasar Hospital, Mangusada Badung Hospital, and the Biomolecular Laboratory, Faculty of Medicine and Health Sciences, Warmadewa University, from November 2022 to April 2023. The samples were paraffin blocks from a radical hysterectomy of patients with cervical carcinoma. The expression of miR-21 was examined by real-time quantitative PCR (RT-qPCR), while p53 and MMP-9 were analyzed by immunohistochemistry (IHC). A total of 40 samples were selected using simple random sampling, consisting of 20 low-grade tumor budding (LGTB) samples (controls) and 20 HGTB samples (cases). Data analysis was performed using SPSS version 24.
This study found that the risk of HGTB significantly increased in miR-21 overexpression (OR=13.222; 95%CI: 2.790-62.670; p-value<0.001) with sensitivity (SN) 70% and specificity (SP) 85%, high mutant p53 expression (OR=44.333; 95%CI: 4.783-410.943; p-value<0.001) with SN=95% and SP=70%, and high MMP-9 expression (OR=10.524; 95%CI: 2.271-48.757; p-value=0.001) with SN=65% and SP=85%. Multivariate analysis showed a significant independent association between mutant p53 expression (aOR=53.676; 95%CI: 3.844-749.474; p-value = 0.003) and high MMP-9 (aOR=13.355; 95%CI: 1.359-131.237; p-value = 0.026), yet miR-21 did not show a significant result.
These findings showed a significant relationship between p53 and MMP-9 expression as pro-oncogenic and pro-invasive molecular factors in HGTB cervical carcinoma.
PMID:
42663214
Bibliographic data and abstract were imported from PubMed on 28 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0